Article
15 Oct 2026
D.C. Circuit Rebuffs Challenge To EPA’s PFOA And PFOS Hazardous Substance Rule
CONTRIBUTING SINCE SEPTEMBER 2013
Dechert
Dechert is the law firm that helps business leaders lead.
For more than 150 years, we have advised clients on critical issues – from high-stakes litigation to first-in-market transaction structures and complex regulatory matters. Our lawyers in commercial centers worldwide are immersed in the key sectors we serve – financial services, private capital, real estate, life sciences and technology.
Dechert delivers unwavering partnership so our clients can achieve unprecedented results.
POPULAR TOPICS
Finance and Banking
Corporate/Commercial Law
Technology
Litigation, Mediation & Arbitration
Antitrust/Competition Law
Dechert are most popular:
- with readers working within the Banking & Credit industries
DETAILS
COMPANY CONTENT
Article
15 Oct 2026
No Diagnosis, No Recommendation, No Recovery: California Court Rejects Explant-Only Injury In Allergan BIOCELL Bellwethers
Article
09 Oct 2026
Dechert Cyber Bits – Issue 104 – October 8, 2026
Article
09 Oct 2026
SEC Proposes To Rescind Rule 14a-8, Modernize Proxy Rules
Article
08 Oct 2026
UK Criminal Attribution Is Live: What Private Credit Firms Must Do
Article
07 Oct 2026
The FCA’s Non-Financial Misconduct Rule: Private Credit In The Regulatory Spotlight
Article
02 Oct 2026
SEC Issues “Innovation Exemption” To Facilitate Trading Of Tokenized NMS Stock
Article
01 Oct 2026
South Korea's US$200 Billion U.S. Program: What Sponsors Must Know
Article
29 Sep 2026
LP-Led CFOs: Their Rise And Key Considerations
Article
29 Sep 2026
Simplification In Action — EU CSRD And CSDDD After The Omnibus I Directive
Article
28 Sep 2026
Five Takeaways From The Private Credit Summit – New York
Article
25 Sep 2026
ABS Market Update: SEC Expands Confidential Draft Registration Review For ABS Issuers
Article
24 Sep 2026
SEC Opens Door To Exchange-Listed, Tokenized Interval Fund Shares
Article
18 Sep 2026
Concierge Medicine And Medical Aesthetics: The Private Equity Playbook For A US$590 Billion Opportunity
Article
15 Sep 2026
Dechert Responds To Ireland’s Public Consultation On Reform Of The Limited Partnership Framework
Article
11 Sep 2026
Dechert Cyber Bits -Issue 102 - September 3, 2026
Article
10 Sep 2026
Duration Is Not Destiny: The NAIC's Proposal For Multi-Collateral Structured Credit Investments
Article
09 Sep 2026
340B Meets The FCA In The Ninth Circuit: What The Pharmaceutical Industry And Investors Need To Know OnPoint Thu Sep 03 2026 The Ninth Circuit's Adventist Decision Lets 340B Covered Entities Bring FCA Qui Tam Suits Over Drug Pricing, Raising New Risks For Manufacturers And Investors.
Article
09 Sep 2026
The UK FCA's Non-Financial Misconduct Rule Is Here – And All Financial Services Firms Are In The Crosshairs
Article
07 Sep 2026
The Emerging Federal Overlay On Healthcare Transactions, Amid Expanding State Review Regimes
